Caco-2 cells as a model for intestinal absorption

Current Protocols in Toxicology

Volumn , Issue SUPPL.47, 2011, Pages

  de Angelis, Isabella ^a   Turco, Laura ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Caco 2 cells; Epithelial barrier; In vitro in vivo correlations; Intestinal absorption; Intestinal in vitro model; Permeability studies

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; BUFFER; CARBON 14; CHEMICAL COMPOUND; LUCIFER YELLOW; MANNITOL; REAGENT;

ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CLINICAL PROTOCOL; CULTURE MEDIUM; DRUG PENETRATION; ELECTRIC RESISTANCE; EXPERIMENTAL DESIGN; EXPERIMENTAL MODEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFORMATION DISSEMINATION; INTESTINE ABSORPTION; PERMEABILITY BARRIER; PREDICTION; PRIORITY JOURNAL; TRANSPORT KINETICS;

EID: 79953290962     PISSN: 19349254     EISSN: 19349262     Source Type: Journal    
DOI: 10.1002/0471140856.tx2006s47     Document Type: Article

References (23)

1. Artursson, P. and Karlsson, J. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Com. 175:880-885.
2. Artursson, P., Palm, K., and Luthman, K. 2001. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46:27-43.
3. Cheng, K-C., Li, C., and Uss, A.S. 2008. Prediction of oral drug absorption in humans from cultured cell lines and experimental animals. Exp. Opin. Drug Metab. Toxicol. 4:581-590.
4. FDA. 2000. Guidance for Industry: Waiver of in vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S.A. Available at: http://www.fda.gov/cder/guidance/3618fnl.pdf.
5. Fogh J., Wright W.C., and Loveless, J.D. 1977. Absence of Hela cell contamination in 169 cell lines derived from human tumours. J. Natl. Cancer Inst. 21:393-408.
6. Gres, M.C., Julian, B., Bourrié, M., Meunier, V., Roques, C., Berger, M., Boulenc, X., Berger, Y., and Fabre, G. 1998. Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: Comparison with the parental Caco-2 cell line. Pharm. Res. 15:726-733.
7. Hayeshi, R., Hilgendorf, C., Artursson, P., Augustijns, P., Brodin, B., Dehertogh, P., Fisher, K., Fossati, L., Hovenkamp, E., Korjamo, T., Masungi, C., Maubon, N., Mols, R., Müllertz, A., Mönkkönen, J., O'Driscoll, C., Oppers-Tiemissen, H.M., Ragnarsson, E.G., Rooseboom, M., and Ungell, A.L. 2008. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories. Eur. J. Pharm. Sci. 35:383-396.
8. Hilgendorf C., Ahlin G., Seithel A., Artursson P., Ungell A.L. and Karlsson J. 2007. Expression of thirty-six drug transporter genes in human intestine, liver, kidney and organotypic cell lines. Drug Metab. Disp. 35:1333-1340.
9. Karlsson, J. and Artursson P. 1991. A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial (Caco-2) cells grown in permeable filter chambers. Int. J. Pharm. 71:55-64.
10. Neuhoff, S., Ungell, A.L., Zamora, I., and Artursson, P. 2005. pH-dependent passive and active transport of acidic drugs across Caco-2 cell monolayer. Eur. J. Pharm. Sci. 25:211-220.
11. Neutra, M. and Louvard, D. 1989. Differentiation of intestinal cells in vitro. In Functional Epithelial Cells in Culture (K.S. Mathin and J.D. Valurtich, eds.) pp. 363-398. Alan R. Liss Inc., New York.
12. Nigsch, F., Klaffe, W., and Miret, S. 2007. In vitro models for processes involved in intestinal absorption. Exp. Opin. Drug Metab. Toxicol. 3:545-556.
13. Pinto, M., Robine-Leon, S., Appay, M.D., Kedinger, M., Triadou, N., Dussaulx, E., Lacroix, B., Simon-Assmann, P., Haffen, K., Fogh, J., and Zweibaum, A. 1983. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47:323-330.
14. Prieto, P., Hoffmann, S., Tirelli, V., Tancredi, F., González, I., Bermejo, M., and De Angelis, I. 2010. An exploratory study of two Caco-2 cell models for oral absorption: A report on their within-laboratory and between-laboratory variability, and their predictive capacity. ATLA 38:367-386.
15. Sambuy, Y., De Angelis, I., Ranaldi, G., Scarino, M.L., Stammati, A., and Zucco, F. 2005. The Caco-2 cell line as a model of the intestinal barrier: Influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol. and Toxicol. 21:1-26.
16. Sun, D., Hans Lennernas, H., Welage, L.S., Barnett, J.L, Landowski, C.P., Foster, D., Fleisher, D., Lee, K.D., and Amidon, G.L. 2002. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm. Res. 19:1400-1416.
17. Sun, H., Chow, E.CY., Liu, S., Du, Y., and Pang, K.S. 2008. The Caco-2 cell monolayer: Usefulness and limitations. Exp. Opin. Drug Metab. Toxicol. 4:395-411.
18. Tavelin, S., Grasjo, J., Taipalensuu, J., Ocklind, G., and Artursson, P. 2002. Applications of epithelial cell culture in studies of drug transport. Methods Mol. Biol. 188:233-272.
19. Thomas, S., Brightman, F., Gill, H., Lee, S., and Pufong, B. 2007. Simulation modelling of human intestinal absorption using Caco-2 permeability and kinetic solubility data for early drug discovery. J. Pharm. Sci. 97:4557-4574.
20. Turco, L., Catone, T., Caloni, F., Di Consiglio, E., Testai, E., and Stammati, A. 2011. Caco-2/TC7 cell line characterization for intestinal absorption: How reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human? Toxicol. in Vitro 25:13-20.
21. van Breemen, R.B. and Li, Y. 2005. Caco-2 cell permeability assays to measure drug absorption. Exp. Opin. Drug Metab. Toxicol. 1:175-185.
22. Yamascita, S., Furubayashi, T., Kataoka, M., Sakane, T., Sezaki, H., and Tokuda, H. 2000. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells. Eur. J. Pharm. Sci. 10:195-204.
23. Yee, S. 1997. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man: Fact or myth. Pharm. Res. 14:763-766.